Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (9595)	5/14/2003 12:54:29 PM
From: Vector1	Respond to of 9719

Torben, I think there is no question the FDA is easing. Iressa, Velcade 3 months early. Very exciting for the industry. A number of controvesial drugs coming up including Biopure's Hemopure in early June. If this trend continues it is an enormous positive for the industry. I would not want to be short this sector right now It could take off like a rocket. CELG, NBIX, OSIP all up over a buck. SEPR up another 63c to almost $22. That stock was written off for dead 6 months ago. I need to update my views on CBST. V1` V1